<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        96-212-99
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ROFENAC 100 MG SUPP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Rectal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suppository
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.40
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac sodium, the active ingredient in Rofenac, is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation. &nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rofenac relieves pain, reduces swelling and eases inflammation in conditions affecting the joints, muscles and tendons including:</p><p>Rheumatoid arthritis, osteoarthritis, acute gout, ankylosing spondylitis</p><p>Backache, sprains and strains, soft tissue sports injuries, frozen shoulder, dislocations and fractures Tendonitis, tenosynovitis, bursitis.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; They are also used to treat pain and inflammation associated with dental and minor surgery.</p><table border="0" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td colspan="3" style="vertical-align:top"><p>&bull; In children aged 1 to 12 Rofenac Suppositories 12.5 and 25 mg are used to treat juvenile</p></td></tr><tr><td style="vertical-align:top"><p>chronic arthritis</p></td><td colspan="2" style="vertical-align:top"><p>.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>&bull; In children aged over 6 they can also be used alone, or in combination with other</p></td><td rowspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>painkillers, for the short term treatment of any pain experienced after an operation.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a. Do not take Rofenac if</p><p>&bull;&nbsp; You think you may be allergic to diclofenac sodium, aspirin, ibuprofen or any other NSAID, or to any of the other ingredients of Rofenac. (These are listed at the end of the leaflet.) Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic type reaction</p><p>&bull;&nbsp; You have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in feces or black, tarry feces)</p><p>&bull;&nbsp; You have had stomach or bowel problems after you have taken other NSAIDs</p><p>&bull;&nbsp; You have severe heart, kidney or liver failure</p><p>&bull;&nbsp; You are more than six months pregnant (see Pregnancy and Lactation).</p><p>&bull;&nbsp; Rofenac suppositories should not be given to children under 12 months of age.</p><p>&nbsp;</p><p>b. Take special care with Rofenac</p><p>&bull;&nbsp; If you suffer from any stomach or bowel disorders including ulcerative colitis or Crohn&#39;s disease</p><p>&bull;&nbsp; If you have kidney or liver problems, or are you elderly</p><p>&bull;&nbsp; If you have a condition called porphyria</p><p>&bull;&nbsp; If you suffer from any blood or bleeding disorder, your doctor may ask you to go for regular check-ups while you are taking these tablets.</p><p>&bull;&nbsp; If you have ever had asthma</p><p>&bull;&nbsp; If you are breast-feeding</p><p>&bull;&nbsp; If you have heart problems, or have you had a stroke, or do you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes or high cholesterol or are a smoker)</p><p>&bull;&nbsp; If you have Lupus (SLE) or any similar condition</p><p>Taking other medicines, herbal or dietary supplements &nbsp;</p><p>Some medicines can interfere with your treatment. Tell your doctor or pharmacist if you are taking any of the following:</p><p>&bull;&nbsp; Medicines to treat diabetes &nbsp;</p><p>&bull;&nbsp; Anticoagulants (blood thinning tablets like warfarin) &nbsp;</p><p>&bull;&nbsp; Diuretics (water tablets).</p><p>&bull;&nbsp; Lithium (used to treat some mental problems).</p><p>&bull;&nbsp; Methotrexate (for some inflammatory diseases and some cancers).</p><p>&bull;&nbsp; Ciclosporin or tacrolimus (used to treat some inflammatory diseases and after transplants).</p><p>&bull;&nbsp; Quinolone antibiotics (for infections).</p><p>&bull;&nbsp; Any other NSAID for example aspirin or ibuprofen or COX-2 (cyclo-oxgenase-2) inhibitor. &nbsp;</p><p>&bull;&nbsp; Mifepristone (a medicine used to terminate pregnancy)</p><p>&bull;&nbsp; Cardiac glycosides (for example digoxin), used to treat heart problems. &nbsp;</p><p>&bull;&nbsp; Medicines known as SSRIs used to treat depression</p><p>&bull;&nbsp; Oral steroids (an anti-inflammatory drug)</p><p>&bull;&nbsp; Medicines used to treat heart conditions or high blood pressure, for example beta- blockers or ACE inhibitors.</p><p>&bull;&nbsp; Sulfinpyrazone (a medicine used to treat gout) or voriconazole (a medicine used to treat fungal infections).</p><p>&bull;&nbsp; Phenytoin (a medicine used to treat seizures)</p><p>&bull;&nbsp; Colestipol/cholestryramine (used to lower cholesterol)</p><p>Always tell your doctor or pharmacist about all the medicines you are taking. &nbsp;This means medicines you have bought yourself as well as medicines on prescription from your doctor.</p><p>e. Pregnancy and Lactation &nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you pregnant or planning to become pregnant? Although not common, abnormalities have been reported in babies whose mothers have taken NSAIDs during pregnancy. &nbsp;</p><p>You should not take Rofenac during the last 3 months of pregnancy as it may affect the baby&rsquo;s circulation.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you trying for a baby? Taking Rofenac may make it more difficult to conceive. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant.</p><p>f. Driving and using machines</p><p>Very occasionally people have reported that Rofenac have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery.</p><p>Other special warnings</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should take the lowest dose of Rofenac for the shortest possible time, particularly if you are underweight or elderly.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There is a small increased risk of heart attack or stroke when you are taking any medicine like Rofenac. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for. &bull; Whilst you are taking these medicines your doctor may want to give you a check-up from time to time.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Because it is an anti-inflammatory medicine, Rofenac may reduce the symptoms of infection, for example, headache and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking Rofenac.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor will tell you how many Rofenac to take and when to take them. Always</p><p>follow his/her instructions carefully.</p><p>&nbsp;If you are not sure, ask your doctor or pharmacist. Keep taking your treatment for as long as you have been told, unless you have any problems. In that case, check with your doctor.</p><p><strong>Suppositories are designed for insertion into the back passage (rectum). Never take them by mouth.&nbsp; </strong></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" align="left" style="width:52px"><tbody><tr><td style="vertical-align:top"><p><strong>Adults: </strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>Rofenac Suppositories are normally inserted one, two or three times a day up to a maximum total daily dose of 150mg. The number of suppositories you need will depend on the strength which the doctor has given you.&nbsp;</p><p>&nbsp;</p><p>Elderly</p><p>Your doctor may advise you to take a dose that is lower than the usual adult dose if you are elderly. Your doctor may also want to check closely that the Rofenac are not affecting your stomach.</p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, or if you are elderly, or taking certain other drugs as well.</p><p>&nbsp;</p><p>Children&nbsp;</p><p><u>For the treatment of chronic juvenile arthritis in children aged 1 to 12:</u>&nbsp;</p><p>Doses vary with age, but are usually between 1 and 3 mg/kg body weight every day divided into 2 or 3 doses.&nbsp;</p><p><u>For the treatment of post-operative pain in children aged 6 and over:</u>&nbsp;</p><p>Doses vary with age, but are usually between 1 and 2 mg/kg body weight per day divided into 2 or 3 doses for no more than 4 days.&nbsp;</p><p>Your child&rsquo;s doctor will work out the dose that is suitable for your child and will tell you how many Rofenac Suppositories to use and how often. Follow his/her instructions carefully. If you are not sure about the dose, check with your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>What if you forget to take a dose?</strong></p><p>If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, though, just take the next dose and forget about the one you missed. Do not double up on the next dose to make up for the one missed. Do not take more than 150 mg in 24 hours.</p><p>&nbsp;</p><p><strong>What if you take too many suppositories?</strong></p><p>If you, or anyone else, accidentally take too much, tell your doctor or your nearest hospital casualty department. Take your medicine pack with you so that people can see what you have taken.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Rofenac are suitable for most people, but, like all medicines, they can sometimes cause side effects.</p><p>Some side effects can be serious</p><p><strong>Stop taking Rofenac and tell your doctor straight away if you notice:</strong></p><p>&bull;&nbsp; Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick)</p><p>&bull;&nbsp; Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels, blood in vomit or black, tarry feces</p><p>&bull;&nbsp; Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering</p><p>&bull;&nbsp; Wheezing or shortness of breath (bronchospasm)</p><p>&bull;&nbsp; Swollen face, lips, hands or fingers</p><p>&bull;&nbsp; Yellowing of your skin or the whites of your eyes</p><p>&bull;&nbsp; Persistent sore throat or high temperature</p><p>&bull;&nbsp; An unexpected change in the amount of urine produced and/or its appearance</p><p>If you notice that you are bruising more easily than usual or have frequent sore throats or infections, tell your doctor.</p><p><strong>The side effects listed below have also been reported.</strong></p><p><strong>Common side effects (<em>These may affect between 1 and 10 in every 100 patients):</em></strong></p><p>&bull;&nbsp; Stomach pain, heartburn, nausea, vomiting, diarrhea, indigestion, wind, loss of appetite</p><p>&bull;&nbsp; Headache, dizziness, vertigo</p><p>&bull;&nbsp; Skin rash or spots</p><p>&bull;&nbsp; Raised levels of liver enzymes in the blood.</p><p><strong>Rare side effects (<em>These may affect between 1 in every 1000 to 1 in every 10,000 patients</em>):</strong></p><p>&bull;&nbsp; Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly)</p><p>&bull;&nbsp; Gastritis (inflammation, irritation or swelling of the stomach lining)</p><p>&bull;&nbsp; Vomiting blood</p><p>&bull;&nbsp; Diarrhea with blood in it or bleeding from the back passage</p><p>&bull;&nbsp; Black, tarry faces or stools</p><p>&bull;&nbsp; Drowsiness, tiredness</p><p>&bull;&nbsp; Hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness) &bull; Skin rash and itching</p><p>&bull;&nbsp; Fluid retention, symptoms of which include swollen ankles</p><p>&bull;&nbsp; Liver function disorders, including hepatitis and jaundice.</p><p><strong>Very rare side effects (<em>These may affect less than 1 in every 10,000 patients</em>):</strong></p><p>Effects on the nervous system:</p><p>Tingling or numbness in the fingers, tremor, blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, mental disorders, disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck, disturbances in sensation.</p><p>Effects on the stomach and digestive system:</p><p>Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the mouth or lips, taste changes, lower gut disorders (including inflammation of the colon or worsening of ulcerative colitis or Crohn&rsquo;s disease).</p><p>Effects on the heart, chest or blood:</p><p>Palpitations (fast or irregular heart beat), chest pain, hypertension (high blood pressure), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), heart disorders, including congestive heart failure or heart attack, blood disorders (including anaemia) and stroke.</p><p>Effects on the liver or kidneys:</p><p>Kidney or severe liver disorders including liver failure, presence of blood or protein in the urine.</p><p>Effects on skin or hair:</p><p>Serious skin rashes including Stevens-Johnson syndrome, Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight.</p><p>Hair loss.</p><p>Other side effects that have also been reported include:</p><p>Inflammation of the pancreas, impotence. Facial swelling, inflammation of the lining of the brain (meningitis), stroke, throat disorders, confusion, hallucinations, malaise (general feeling of discomfort), inflammation of the nerves in the eye.</p><p>&nbsp;</p><p><strong>Do not be alarmed by this list - most people take Rofenac without any problems.</strong> <strong>If any of the symptoms become troublesome, or if you notice anything else not mentioned here, please go and see your doctor. He/she may want to give you a different medicine. </strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store in a dry place, below 30&deg;C. Keep the suppositories in their original pack.&nbsp;</p><p>Keep out of the reach and sight of children.</p><p>Do not take Rofenac after the expiry date which is printed on the outside of the pack. If your doctor tells you to stop taking the suppositories, please take any unused suppositories back to your pharmacist to be destroyed. Do not throw them away with your normal household water or waste. This will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each Rofenac suppository contains 12.5 mg diclofenac sodium. - Rofenac suppositories also contain the inactive ingredients which are: Excipients:</p><p>Witepsol H-15, Witepsol w-35</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Rofenac 12.5 mg Suppository: Ivory-colored, torpedo shaped suppositories. 
Contents of pack: 
Each Rofenac 12.5 mg suppository pack contains 10 suppositories
 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO</p><p>AlQassim pharmaceutical plant</p><p>Saudi Pharmaceutical Industries &amp; Medical Appliance Corporation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                August 2016. 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>دايكلوفيناك صوديوم( المادة الفعالة فى روفيناك) تنتمى لمجموعة من الأدوية تسمى مضادات الالتھابات غير الإستيرويدية وھى تستخدم فى تقليل الألم والالتھاب.</p><p>&bull;&nbsp; روفيناك يسكن الألم و يقلل التورم و الالتھابات فى الحالات التى تؤثر فى المفاصل والعضلات و الأوتار وھى:</p><p>التھاب المفاصل الروماتويدى و التھاب المفاصل المفصلى و النقرص الحاد و التھاب الفقرات وآلام الظھر و الالتواء و اصابات الأنسجة الرخوة نتيجة ممارسة الرياضة و تيبس الكتف وحالات الخلع والكسور و التھاب الأوتار والتھاب غمد الأوتار و الالتھاب الكيسى.</p><p>&bull;&nbsp; كما يستخدم أيضا فى علاج حالات ألم والتھاب الأسنان والعمليات الجراحية الصغيرة.</p><p>&bull;&nbsp; في الأطفال الذين تتراوح أعمارھم بين 1-21 سنة&nbsp; تستخدم تحاميل روفيناك 125. و 52&nbsp; ملجم لعلاج التھاب</p><p>المفاصل المزمن في الصغار .</p><p>&bull;&nbsp; في الأطفال الذين تزيد أعمارھم عن 6 سنوات ويمكن أيضا أن تستخدم وحدھا أو بالاشتراك مع مسكنات الألم الأخرى، من أجل العلاج على المدى القصير من أي الألم الذي تعانيه بعد العملية.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>امتنع عن استخدام روفيناك فى الحالات الآتية:</p><p>&nbsp;&bull;اذا كنت تعتقد أنه لديك حساسية ل دايكلوفيناك صوديوم أو اسبيرين أو ايبوبروفين أو أى دواء مضاد للالتھابات غير ستيرويدى آخر أو لأى من المكونات الأخرى ل روفيناك. (والمذكورة فى آخر ھذه النشرة).أعراض فرط التحسس ھى تورم الوجه و الفم ومشاكل فى التنفس و سيلان الأنف و حكة فى الجلد أو أى نوع آخر من أنواع تفاعلات الحساسية .</p><p>&bull;&nbsp; اذا كنت تعانى أو عانيت من قرحة فى المعدة أو الاثنى عشر أو نزيف فى الجھاز الھضمى (وھو قد يسبب وجود دم فى القيئ أو نزيف اثُناء افراغ الأمعاء أو وجود دم فى البراز أو تغير لون البراز إلى اللون الأسود القطرانى) &bull; اذا تعرضت لمشاكل فى المعدة أو الأمعاء بعد تناولك لدواء مضاد للالتھابات غير ستيرويدى آخر.</p><p>&bull;&nbsp; اذا كنت تعانى من مشاكل حادة فى القلب أو الكلية أو فشل كبدى.</p><p>&bull;&nbsp; اذا كنتى حامل فى فترة أكثر من الشھر السادس (انظرى فقرة الحمل والرضاعة).</p><p>&bull;&nbsp; يجب ألا تستخدم روفيناك تحاميل فى الأطفال أقل من 21 شھر .</p><p>ينبغى توخى الحذر عند استخدام روفيناك:</p><p>&bull;&nbsp; اذا كنت تعانى من أى امراض فى المعده أو الأمعاء بما فى ذلك التھاب القولون التقرحى أو مرض كروھن</p><p>&bull;&nbsp; اذا كنت تعانى من مشاكل فى الكلية أو الكبد أو اذا كنت من كبار السن</p><p>&bull;&nbsp; اذا كان لديك حالة من حالات البورفيريا</p><p>&bull;&nbsp; اذا كنت تعانى من أى مشاكل فى الدم أو مشاكل متعلقة بالنزيف ولذلك قد يطلب منك الطبيب أن تقوم بعمل فحوصات دورية اثناء تناولك ھذا الدواء</p><p>&bull;&nbsp; اذا كنت تعانى فى أى وقت من الأوقات من الربو</p><p>&bull;&nbsp; اذا كنت ترضعين طفلك رضاعة طبيعية</p><p>&bull;&nbsp; اذا كنت تعانى من مشاكل فى القلب أو تعرضت للسكتة الدماغية أو اذا كنت تعتقد أنك فى خطر من ھذه الأمراض</p><p>(مثل اذا كنت تعانى من ارتفاع فى ضغط الدم أو السكر أو الكوليستيرول أو اذا كنت مدخنا)&nbsp;</p><p>&bull;&nbsp; اذا كنت تعانى من مرض الذئبة أو أى حالة مشابھة</p><p><strong>تناول أدوية أخرى أو أعشاب أو مكملات غذائية </strong></p><p>بعض الأدوية قد تتعارض مع ھذا الدواء فضلا اخبر طبيبك أو الصيدلى اذا كنت تأخد أى من الأدوية التالية:</p><p>الأدوية التى تستخدم فى علاج داء السكرى .</p><p>&bull;&nbsp; الادوية المضادة للتجلط (الأدوية التى تزيد سيولة الدم مثل وارفارين).<strong> </strong>&nbsp;</p><p>&bull;&nbsp; مدرات البول.</p><p>&nbsp;&bull;الليثيوم( يستخدم لعلاج بعض الأمراض العقلية).</p><p>&bull;&nbsp; ميثوتريكسات( يستخدم لعلاج بعض أمراض الالتھابات و بعض أمراض السرطان).</p><p>&nbsp;&bull;سيكلوسبورين أو تاكروليميس (يستخدم لعلاج بعض أمراض الالتھابات وبعد زراعة الأعضاء).</p><p>&bull;&nbsp; كينولون( مضادات حيوية تستخدم لعلاج العدوى).</p><p>&bull;&nbsp; أى دواء مضاد للالتھابات غير ستيرويدى أخر (مثل: اسبيرين أو ايبوبروفين)&nbsp; أو مضاد لانزيم كوكس-2.</p><p>&bull;&nbsp; ميفيبريستون( دواء يستخدم لانھاء الحمل)</p><p>&bull;&nbsp; الجليكوسايد القلبية (مثل: ديجوكسين الذى يستخدم لعلاج مشاكل القلب).&nbsp;</p><p>&bull;&nbsp; الأدوية المعروفة ب مضادات امتصاص السيروتونين والتى تستخدم لعلاج الاكتئاب.</p><p>&bull;&nbsp; الستيرويد التى تستخدم عن طريق الفم والتى تستخدم لعلاج الالتھابات</p><p>&bull;&nbsp; الأدوية التى تستخدم لعلاج مشاكل القلب أو ارتفاع ضغط الدم مثل الأدوية التى تغلق مستقبلات بيتا أو تثبط عمل&nbsp; الانزيم المحول لانجيوتنسين</p><p>&bull;&nbsp; سلفيبيرازون (علاج للنقرص) أو فوريكونازول (علاج العدوى الفطرية)</p><p>&bull;&nbsp; فينيتوين( علاج للنوبات التشنجية)</p><p>&bull;&nbsp; كولستيبول/ كوليستيرامين (لتقليل الكوليستيرول)</p><p>لذلك دائما اخبر طبيبك أو الصيدلى بالأدوية التى تتناولھا بما فى ذلك الأدوية التى وصفھا لك طبيب آخر أو حتى الأدوية بدون وصفة طبية</p><p><strong>الحمل والرضاعة</strong>&nbsp;</p><p>اذا كنتى حامل لا تستخدمى روفيناك فى آخر 3 شھور فى الحمل لأن ذلك قد يؤثر على الدورة الدموية لطفلك حتى مع عدم شيوع حدوث تشوھات فى الأطفال التى تستخدم أمھاتھم أدوية مضاده للالتھابات غير ستيرويدى.</p><p>اذا كنتى تخططى للحمل استخدامك لـ روفيناك قد يجعل الحمل صعبا ولذلك يجب أن تخبرى طبيبك أنك تخططين للحمل أو أنك تواجھين مشاكل فى حدوث الحمل</p><p><strong>القيادة واستخدام الآلات</strong></p><p>فى بعض الأحيان يوجد بعض الحالات التى جعل فيھا روفيناك المرضى يشعرون بالدوار أوالتعب أو النعاس أو مشاكل فى رؤية العين لذلك اذا شعرت بأى من ھذه الأعراض لا تقود أو تستخدم الآلات&nbsp;</p><p><strong>بعض التحذيرات الأخرى</strong></p><p>&bull;&nbsp; ينبغى أن تستخدم أقل جرعة من تحاميل روفيناك لأقل وقت ممكن خصوصا اذا كنت تحت الوزن المطلوب أو اذا كنت من كبار السن</p><p>&bull;&nbsp; يوجد زيادة قليلة فى خطورة حدوث أزمة قلبية أو سكتة دماغية عند استخدام أدوية مثل روفيناك وتزيد الخطورة بزيادة الجرعة و مدة العلاج لفترة طويلة لذلك يجب اتباع نصائح طبيبك عن جرعة و مدة العلاج&nbsp;</p><p>&bull;&nbsp; قد يطلب منك طبيبك عمل فحوص دورية من وقت إلى آخر عند استخدامك<strong> </strong>لھذا العلاج</p><p>&bull;&nbsp; اذا كان لديك تاريخ مرضى لمشاكل فى المعدة عند تناولك الأدوية المضادة للالتھابات غير الستيرويدى خصوصا اذا كنت من كبار السن ولذلك اخبر طبيبك فورا اذا لاحظت أى أعراض غير طبيعية</p><p>&bull;&nbsp; لأن روفيناك دواء مضاد للالتھاب فھو قد يقلل أعراض العدوى مثل الصداع وارتفاع درجة الحرارة ولذلك اذا شعرت بالمرض أو الحاجة لزيارة الطبيب اخبر طبيبك أنك تستخدم روفيناك&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سوف يخبرك الطبيب عن عدد تحاميل روفيناك&nbsp; التى تأخذھا ومتى تأخذھا.اتبع تعليمات طبيبك بعناية .</p><p>اذا كنت غير متأكد اسأل طبيبك أو الصيدلى واستخدم روفيناك للمدة التى اخبرك الطبيب بھا إلا اذا واجھتك أى مشاكل فى ھذه الحالة راجع طبيبك.</p><p><strong>تم تصميم التحاميل لإدراجھا في الدبر (الشرج) .لا تأخذھا عن طريق الفم.</strong><strong>&nbsp; </strong></p><p><strong>البالغين:</strong><strong> </strong></p><p>يتم إدراج تحاميل روفيناك عادة مرة واحدة أو اثنين أو ثلاث مرات في اليوم بحيث يصل إلى أقصى جرعة يومية من 051 ملجم .عدد التحاميل التي تحتاج إليھا سوف تعتمد على التركيز الذي أعطاك الطبيب.</p><p><strong>كبار السن:</strong></p><p>سوف يقوم الطبيب باخبارك عن كيفية استخدام الدواء بجرعة أقل من الجرعة المعتادة اذا كنت من كبار السن كما قد يطلب الطبيب الفحص بدقة كى يتأكد الطبيب أن روفيناك لايؤثر على معدتك.</p><p>قد يصف لك الطبيب دواء آخر ليحمى المعدة فى نفس الوقت خصوصا اذا كنت عانيت من مشاكل فى المعدة من قبل أو اذا كنت من كبار السن أو اذا كنت تأخذ أدوية معينه.&nbsp;</p><p><strong>الأطفال:</strong><strong> </strong></p><p>لعلاج التھاب المفاصل المزمن بالأحداث في الصغار الذين تتراوح أعمارھم بين 1-21 سنة:</p><p>تختلف الجرعات مع تقدم العمر، ولكن عادة ما تكون بين 1 و 3 ملجم / كجم من وزن الجسم كل يوم مقسمة إلى 2 أو 3 جرعات.</p><p>لعلاج الألم بعد العمليات الجراحية عند الأطفال الذين تكون أعمارھم 6 سنوات أو اكثر:</p><p>تختلف الجرعات مع تقدم العمر، ولكن عادة ما تكون بين 1 و 2 ملجم / كجم من وزن الجسم يوميا مقسمة إلى 2 أو3 &nbsp;جرعات لمدة لا تزيد عن 4 أيام.</p><p>سوف يختار طبيب طفلك الجرعة المناسبة لطفلك وسوف يقول لكم عدد تحاميل روفيناك و مدة استخدامھا. اتبع تعليماته بعناية .إذا كنت غير متأكدة من الجرعة، تحقق مع طبيبك أو الصيدلي.&nbsp;</p><p>&nbsp;</p><p><strong>اذا نسيت تعاطى جرعة روفيناك&nbsp;&nbsp; </strong></p><p>اذا نسيت تعاطى جرعة من روفيناك&nbsp; خذھا عندما تتذكر أما اذا كان الوقت قريب جدا من الجرعة التالية خذ الجرعة التالية فى وقتھا و لا تأخد الجرعتين لتعويض الجرعة المنسية ولا تأخذ اكثر من 051 مجم&nbsp; فى اليوم .</p><p><strong>اذا أخذت العديد من تحاميل روفيناك&nbsp; </strong></p><p>اذا أخذت أنت أو أى شخص بصورة عرضية العديد من التحاميل اخبر الطبيب أو توجه الى أقرب مستشفى وخذ معك علبة الدواء حتى يعرفوا الدواء الذى استخدمته.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>روفيناك مناسب لمعظم المرضى ولكنه مثل جميع الأدوية قد يسبب بعض الأعراض الجانبية بعض الأعراض الجانبية قد تكون خطيرة.</p><p>توقف عن استخدام روفيناك واخبر طبيبك فورا اذا لاحظت أى من الأعراض الجانبية التالية:</p><p>&bull;&nbsp; ألم فى المعدة أو سوء ھضم أوحموضة أو غازات أو غثيان او قيئ</p><p>&bull;&nbsp; أى دلائل على وجود نزيف فى المعدة أو الأمعاء مثل نزيف عند افراغ الأمعاء أو وجود دم فى القيئ أو تحول لون البراز إلى اللون الأسود القطرانى&nbsp;</p><p>&bull;&nbsp; تفاعلات حساسية والتى تشمل طفح جلدى أو حكه أو وجود مناطق حمراء مؤلمة أو تقشر الجلد</p><p>&bull;&nbsp; صفير أو قصر فى النفس (تشنج قصبى)</p><p>&bull;&nbsp; تورم الوجه والشفاه والأيدى و الأصابع</p><p>&bull;&nbsp; اصفرار الجلد أو اصفرار بياض العين</p><p>&bull;&nbsp; احتقان مستمر فى الحلق أو ارتفاع فى درجة الحرارة</p><p>&bull;&nbsp; تغير غير متوقع فى كمية البول مع أو بدون تغير مظھره</p><p>اذا لاحظت أنك اكثر عرضه للكدمات أو احتقان فى الحلق أو العدوى من المعتاد اخبر طبيبك الأعراض الجانبية التى تم رصدھا&nbsp;&nbsp;</p><p>أعراض جانبية شائعة (قد تؤثر فى من 1 إلى 01 فى كل 001 مريض:)</p><p>&bull;&nbsp; ألم فى المعدة أوحموضة أو غثيان أو قيئ أو اسھال أو سوء ھضم أو غازات أو فقدان فى الشھيه</p><p>&bull;&nbsp; صداع أو دوار أو دوخه</p><p>&bull;&nbsp; طفح جلدى أو بقع جلدية</p><p>&bull;&nbsp; ارتفاع فى مستوي انزيمات الكبد فى الدم</p><p>أعراض جانبية نادرة (قد تؤثر فى 1 من كل0001 إلى 1 من كل 00001 مريض:)</p><p>&bull;&nbsp; قرحه أو نزيف فى المعدة (تم رصد حالات نادرة جدا سببت الموت خاصة من كبار السن)</p><p>&bull;&nbsp; التھاب فى المعدة (التھاب أو تھيج أو تورم فى الغشاء المبطن للمعدة)</p><p>&bull;&nbsp; وجود دم فى القيئ</p><p>&bull;&nbsp; اسھال مع وجود دم أو نزيف</p><p>&bull;&nbsp; براز بلون أسود قطرانى</p><p>&bull;&nbsp; نعاس أو تعب أو ارھاق</p><p>&bull;&nbsp; انخفاض ضغط الدم (وأعراضه الأغماء أو دوار أو صداع)</p><p>&bull;&nbsp; طفح جلدى و حكه</p><p>&bull;&nbsp; احتباس السوائل وأعراضه تورم الكاحلين</p><p>&bull;&nbsp; اضطراب فى وظائف الكبد بما فى ذلك التھاب الكبد و الصفراء أعراض جانبية نادرة جدا( قد تؤثر فى أقل من 1 فى كل 00001 مريض:) تتعلق بالجھاز العصبى:</p><p>وخز أو خدر فى الأصابع أو رعشة أو اضطراب فى الرؤية مثل عدم وضوح الرؤية أو ثنائية الرؤية أو فقد أو اضطراب السمع أو طنين (صوت أجراس فى الأذن) و عدم القدرة على النوم و كوابيس أو تقلبات مزاجية أو اكتئاب أو قلق أو اضطرابات عقلية أو الضياع أو فقد الذاكرة أو تشنجات أو صداع مع كره الضوء الساطع أو حمى أو تصلب الرقبة أو اضطرابات فى الأحساس تتعلق بالمعدة و الجھاز الھضمى :</p><p>إمساك و التھاب فى اللسان أو تقرحات فى الفم أو التھابات فى داخل الفم و الشفاه أو تغييرات فى الأحساس بالطعم أو اضطرابات فى الجھاز الھضمى السفلى (بما فى ذلك التھاب فى القولون أو ازدياد حالة قرحة القولون سوءا أو مرض كروھن)</p><p>تتعلق بالقلب أو الصدر أوالدم :</p><p>خفقان( سرعة أوعدم انتظام ضربات القلب) أو ألم فى الصدر أو ارتفاع ضغط الدم أو التھاب فى الأوعية الدموية أو التھاب فى الرئة أو اضطرابات فى القلب بما فى ذلك فشل القلب الاحتقانى أو نوبات القلب أو اضطرابات فى الدم</p><p>(مثل الأنيميا) و السكتة الدماغية تتعلق بالكبد و الكلى :</p><p>اضطرابات حادة فى الكلى أو الكبد بمل فى ذلك الفشل الكبدى و وجود دم أو بروتين فى البول تتعلق بالجلد أو الشعر :</p><p>طفح جلدى حاد بما فى ذلك ظاھرة ستيفينز جونسون و ظاھرة لايل و أنواع اخرى من الطفح الجلدى والتى قد تسوء بالتعرض لضوء الشمس فقد الشعر</p><p>أعراض جانبية اخرى تم رصدھا</p><p>التھاب فى البنكرياس أو العجز الجنسى أو تورم فى الوجه أو التھاب سحائى أو سكتة دماغية أو اضطرابات فى الحلق أو ارتباك أو ھلوسة أو شعور عام بالتعب أو التھاب فى أعصاب العين</p><p>لا تقلق من ھذه القائمة من الأعراض الجانبية لأن معظم المرضى يتناولون روفيناك بدون أى مشاكل.</p><p>اذا زادت أى من ھذه الأعراض أو اذا لاحظت أعراض اخرى غير المذكورة ھنا استشر طبيبك فربما يصف لك دواء آخر&nbsp; .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تحفظ في مكان جاف، أقل من 30 درجة مئوية. احفظ التحاميل في العبوة الأصلية.&nbsp;</p><p>احفظھا بعيد عن متناول ورؤية الأطفال</p><p>لا تأخذ تحاميل روفيناك بعد تاريخ الصلاحية الموجود على العبوة.</p><p>اذا اخبرك طبيبك أن تتوقف عن تعاطى تحاميل روفيناك فضلا خذ التحاميل الغير مستخدمة للصيدلى ليتخلص منھا.</p><p>لا تتخلص منھم فى الماء أو النفايات المنزلية. ذلك سوف يساعد على حماية البيئة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>● يحتوى روفيناك على&nbsp;</p><p>كل تحميلة من روفيناك تحتوى على 12.5 مجم&nbsp; من دايكلوفيناك صوديوم ● يحتوى روفيناك تحاميل أيضا على مواد غير فعالة وھى:</p><p>السواغات:</p><p>ويتبسول اتش15- و ويتبسول دبليو-53.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>روفيناك 12.5 مجم تحاميل: تحميلة لونھا عاجى وتشبه التوربيدو (قذيفة نسف السفن)&nbsp; محتويات العبوة: كل عبوة روفيناك 12.5 مجم تحاميل تحتوى على10 تحاميل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>إنتاج الدوائية مصنع الأدوية بالقصيم</p><p>الشركة السعودية للصناعات الدوائية والمستلزمات الطبية.</p><p>المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أغسطس 2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rofenac® 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active substance is sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate
(diclofenac sodium).
Each suppository contains 12.5 mg or 25 mg or 50 or 100 mg diclofenac sodium
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suppository. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Rofenac 25mg, 50mg and 100mg suppositories</u><br /><em>Adults and Elderly:</em><br />Relief of all grades of pain and inflammation in a wide range of conditions,<br />including:<br />(i) arthritic conditions: rheumatoid arthritis, osteoarthritis, ankylosing spondylitis,<br />acute gout,<br />(ii) acute musculo-skeletal disorders such as periarthritis (for example frozen<br />shoulder), tendinitis, tenosynovitis, bursitis,<br />(iii) other painful conditions resulting from trauma, including fracture, low back pain,<br />sprains, strains, dislocations, orthopedic, dental and other minor surgery.<br />Rofenac 50mg and 100mg suppositories are not indicated for use in children.<br />&nbsp;</p><p><u>Rofenac 12.5mg and 25mg suppositories only</u><br />Children (aged 1-12 years): Juvenile chronic arthritis<br />Children (aged 6 years and above): As monotherapy or as adjunct therapy with<br />morphine or other opiates (due to its opiate-sparing effect) for the relief of acute postoperative<br />pain.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimized by using the lowest effective dose for the<br />shortest duration necessary to control symptoms (see section 4.4 Special warnings<br />and precautions for use).<br />Not to be taken by mouth, as per rectal administration only.<br />The suppositories should be inserted well into the rectum. It is recommended to insert the<br />suppositories after passing stools.<br /><strong>Adults</strong>:<br />75-150mg daily, in divided doses (25mg, 50mg and 100mg suppositories only).<br />The recommended maximum daily dose of Rofenac is 150mg. This may be administered<br />using a combination of dosage forms, e.g. tablets and suppositories. (25mg and 50mg<br />suppositories only).<br />100mg suppositories may also be given as a once daily treatment, usually at night. Where<br />necessary, therapy may be combined with 25mg or 50mg tablets or suppositories up to the<br />maximum dose of 150mg per day.<br />&nbsp;</p><p><strong>Special populations<br />Elderly:</strong><br />Although the pharmacokinetics of Rofenac are not impaired to any clinically relevant<br />extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with<br />particular caution in such patients who generally are more prone to adverse reactions.<br />In particular it is recommended that the lowest effective dosage be used in frail<br />elderly patients or those with a low body weight (see also Precautions) and the patient<br />should be monitored for GI bleeding during NSAID therapy.<br />&nbsp;</p><p><strong>Renal impairment</strong><br />Diclofenac is contraindicated in patients with severe renal impairment (see section<br />4.3). No specific studies have been carried out in patients with renal impairment,<br />therefore, no specific dose adjustment recommendations can be made. Caution is<br />advised when administering diclofenac to patients with mild to moderate renal<br />impairment (see section 4.3 and 4.4).<br />&nbsp;</p><p><strong>Hepatic impairment</strong><br />Diclofenac is contraindicated in patients with severe hepatic impairment (see section<br />4.3). No specific studies have been carried out in patients with hepatic impairment,<br />therefore, no specific dose adjustment recommendations can be made. Caution is<br />advised when administering diclofenac to patients with mild to moderate hepatic<br />impairment (see section 4.3 and 4.4).<br />&nbsp;</p><p><strong>Paediatric population</strong><br />Children (aged 1-12 years) with juvenile chronic arthritis: 1-3mg/kg per day divided<br />into 2 or 3 doses (12.5mg and 25mg suppositories only).<br />Children (aged 6-12 years) with acute post-operative pain: 1-2mg/kg per day in<br />divided doses.<br />Treatment of acute post-operative pain should be limited to 4 days treatment (12.5mg<br />and 25mg suppositories only).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or any of the excipients.
• Active, gastric or intestinal ulcer, bleeding or perforation.
• History of gastrointestinal bleeding or perforation, relating to previous NSAID
therapy
• Active, or history of recurrent peptic ulcer/hemorrhage (two or more distinct
episodes of proven ulceration or bleeding).
• Last trimester of pregnancy (see section 4.6 Pregnancy and lactation).
• Severe hepatic, renal or cardiac failure (see section 4.4 Special warnings and
precautions for use).
• Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also
contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute
rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal antiinflammatory
drugs.
• Proctitis
• Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral
arterial disease and/or cerebrovascular disease
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong><br />Undesirable effects may be minimized by using the lowest effective dose for the<br />shortest duration necessary to control symptoms (see section 4.2 Posology and<br />method of administration and GI and cardiovascular risks below).<br />The concomitant use of Rofenac with systemic NSAIDs including cyclooxygenase-2<br />selective inhibitors should be avoided due to the absence of any evidence<br />demonstrating synergistic benefits and the potential for additive undesirable effects<br />(see section 4.5 Interactions with other medicaments and other forms of interaction).<br />Caution is indicated in the elderly on basic medical grounds. In particular, it is<br />recommended that the lowest effective dose be used in frail elderly patients or those<br />with a low body weight (see section 4.2 Posology and Method of administration)<br />As with other nonsteroidal anti-inflammatory drugs including diclofenac , allergic<br />reactions, including anaphylactic/anaphylactoid reactions, can also occur without<br />earlier exposure to the drug (see section 4.8 Undesirable effects).<br />Like other NSAIDs, diclofenac may mask the signs and symptoms of the infection<br />due to its pharmacodynamic properties.</p><p><strong>Gastrointestinal effects:</strong><br />Gastrointestinal bleeding (haematemesis, melaena) ulceration or perforation which<br />can be fatal has been reported with all NSAIDs including diclofenac and may occur at<br />any time during treatment, with or without warning symptoms or a previous history<br />of serious GI events. They generally have more serious consequences in the elderly.<br />If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the<br />drug should be withdrawn.<br />As with all NSAIDs, including diclofenac close medical surveillance is imperative<br />and particular caution should be excised when prescribing diclofenac in patients with<br />symptoms indicative of gastrointestinal disorders, or with a history suggestive of<br />gastric or intestinal ulceration, bleeding or perforation (see section 4.8 Undesirable<br />effects). The risk of GI bleeding, ulceration or perforation is higher with increasing<br />NSAID doses including diclofenac, and in patients with a history of ulcer,<br />particularly if complicated with haemorrhage or perforation.<br />The elderly have increased frequency of adverse reactions to NSAIDs especially<br />gastro intestinal bleeding and perforation which may be fatal (see section 4.2<br />Posology and method of administration).<br />To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if<br />complicated with hemorrhage or perforation, and in the elderly, the treatment should<br />be initiated and maintained at the lowest effective dose.<br />Combination therapy with protective agents (e.g. misoprostol or proton pump<br />inhibitors) should be considered for these patients, and also for patients requiring<br />concomitant use of medicinal products containing low dose acetylsalicylic acid<br />(ASA/aspirin or medicinal products likely to increase gastrointestinal risk. (See<br />section 4.5 Interactions with other medicaments and other forms of interaction).<br />Patients with a history of GI toxicity, particularly when elderly, should report any<br />unusual abdominal symptoms (especially GI bleeding).<br />Caution is recommended in patients receiving concomitant medications which could<br />increase the risk of ulceration or bleeding, such as systemic corticosteroids,<br />anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or<br />anti-platelet agents such as acetylsalicylic acid (see section 4.5 Interaction with other<br />medicaments and other forms of interaction).<br />Close medical surveillance and caution should be exercised in patients with ulcerative<br />colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section<br />4.8 Undesirable effects).</p><p><strong>Hepatic effects:</strong><br />Close medical surveillance is required when prescribing Rofenac to patients with<br />impairment of hepatic function as their condition may be exacerbated.<br />As with other NSAIDs, including diclofenac, values of one or more liver enzymes<br />may increase. During prolonged treatment with Diclofenac, regular monitoring of<br />hepatic function is indicated as a precautionary measure.<br />If abnormal liver function tests persist or worsen, clinical signs or symptoms<br />consistent with liver disease develop or if other manifestations occur (eosinophilia,<br />rash), Rofenac should be discontinued.<br />Hepatitis may occur with diclofenac without prodromal symptoms.<br />Caution is called for when using diclofenac in patients with hepatic porphyria, since it<br />may trigger an attack.</p><p><strong>Renal effects:</strong><br />As fluid retention and oedema have been reported in association with NSAIDs<br />therapy, including diclofenac, particular caution is called for in patients with impaired<br />cardiac or renal function, history of hypertension, the elderly, patients receiving<br />concomitant treatment with diuretics or medicinal products that can significantly<br />impact renal function, and those patients with substantial extracellular volume<br />depletion from any cause, e.g. before or after major surgery (see section 4.3<br />Contraindications). Monitoring of renal function is recommended as a precautionary<br />measure when using diclofenac in such cases. Discontinuation therapy is usually<br />followed by recovery to the pre-treatment state.</p><p><strong>Skin effects:</strong><br />Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-<br />Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in<br />association with the use of NSAIDs, including Rofenac (see section 4.8 Undesirable<br />effects). Patients appear to be at the highest risk of these reactions early in the course<br />of therapy: the onset of the reaction occurring in the majority of cases within the first<br />month of treatment. Rofenac should be discontinued at the first appearance of skin<br />rash, mucosal lesions or any other signs of hypersensitivity.</p><p><strong>SLE and mixed connective tissue disease:</strong><br />In patients with systemic lupus erythematosus (SLE) and mixed connective tissue<br />disorders there may be an increased risk of aseptic meningitis (see section 4.8<br />Undesirable effects).</p><p><strong>Cardiovascular and cerebrovascular effects:</strong><br />Patients with significant risk factors for cardiovascular events (e.g. hypertension,<br />hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac<br />after careful consideration. As the cardiovascular risks of diclofenac may increase<br />with dose and duration of exposure, the shortest duration possible and the lowest<br />effective daily dose should be used. The patient&#39;s need for symptomatic relief and<br />response to therapy should be re-evaluated periodically.<br />Appropriate monitoring and advice are required for patients with a history of<br />hypertension and/or mild to moderate congestive heart failure as fluid retention and<br />edema have been reported in association with NSAID therapy including diclofenac.<br />Clinical trial and epidemiological data consistently point towards increased risk of<br />arterial thrombotic events (for example myocardial infarction or stroke) associated<br />with the use of diclofenac, particularly at high dose (150mg daily) and in long term<br />treatment.<br />Patients with uncontrolled hypertension, congestive heart failure, established<br />ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease<br />should only be treated with diclofenac after careful consideration.</p><p><strong>Hematological effects:</strong><br />During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of<br />the blood count is recommended.<br />Rofenac may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5<br />Interaction with other medicaments and other forms of interactions). Patients with<br />defects of haemostasis, bleeding diathesis or hematological abnormalities should be<br />carefully monitored.</p><p><strong>Pre-existing asthma:</strong><br />In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e.<br />nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the<br />respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on<br />NSAIDs like asthma exacerbations (so called intolerance to analgesics / analgesics<br />asthma), Quincke&#39;s oedema or urticaria are more frequent than in other patients.<br />Therefore, special precaution is recommended in such patients (readiness for<br />emergency). This is applicable as well for patients who are allergic to other<br />substances, e.g. with skin reactions, pruritus or urticaria.<br />Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and<br />other NSAIDs can precipitate bronchospasm if administered to patients suffering<br />from, or with a previous history of bronchial asthma.</p><p><strong>Female fertility:</strong><br />The use of Rofenac may impair female fertility and is not recommended in women<br />attempting to conceive. In women who may have difficulties conceiving or who are<br />undergoing investigation of infertility, withdrawal of Rofenac should be considered<br />(see section 4.6 Pregnancy and Lactation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with diclofenac gastro-resistant<br />tablets and/or other pharmaceutical forms of diclofenac.<br /><strong>Lithium:</strong> If used concomitantly, Rofenac may increase plasma concentrations of<br />lithium. Monitoring of the serum lithium level is recommended.<br />&nbsp;</p><p><strong>Digoxin</strong>: If used concomitantly, Rofenac may raise plasma concentrations of digoxin.<br />Monitoring of the serum digoxin level is recommended.</p><p><strong>Diuretics and antihypertensive agents:</strong> Like other NSAIDs, concomitant use of<br />Rofenac with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin<br />converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive<br />effect via inhibition of vasodilatory prostaglandin synthesis.<br />Therefore, the combination should be administered with caution and patients,<br />especially the elderly, should have their blood pressure periodically monitored.<br />Patients should be adequately hydrated and consideration should be given to<br />monitoring of renal function after initiation of concomitant therapy periodically<br />thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of<br />nephrotoxicity. Concomitant treatment with potassium-sparing diuretics may be<br />associated with increased serum potassium levels, which should therefore be<br />monitored frequently (see section 4.4 Special warnings and precautions for use).</p><p><strong>Anticoagulants and anti-platelet agents:</strong> Caution is recommended since<br />concomitant administration could increase the risk of bleeding (see section 4.4<br />Special warnings and precautions for use). Although clinical investigations do not<br />appear to indicate that Rofenac has an influence on the effect of anticoagulants, there<br />are isolated reports of an increased risk of hemorrhage in patients receiving<br />diclofenac and anticoagulant concomitantly (see section 4.4 Special warnings and<br />precautions for use). Therefore, to be certain that no change in anticoagulant dosage<br />is required, close monitoring of such patients is required. As with other nonsteroidal<br />anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet<br />aggregation.</p><p><strong>Other NSAIDs including cyclooxygenase-2 selective inhibitors and<br />corticosteroids: </strong>Co-administration of diclofenac with other systemic NSAIDs or<br />corticosteroids may increase the risk of gastrointestinal bleeding or ulceration. Avoid<br />concomitant use of two or more NSAIDs (see section 4.4 Special warnings and<br />precautions for use).</p><p><strong>Selective serotonin reuptake inhibitors (SSRIs):</strong> Concomitant administration of<br />SSRI&#39;s may increase the risk of gastrointestinal bleeding (see section 4.4 Special<br />warnings and precautions for use).</p><p><strong>Antidiabetic:</strong> Clinical studies have shown that Rofenac can be given together with<br />oral antidiabetic agents without influencing their clinical effect. However there have<br />been isolated reports of hypoglycemic and hyperglycemic effects necessitating<br />changes in the dosage of the antidiabetic agents during treatment with diclofenac. For<br />this reason, monitoring of the blood glucose level is recommended as a precautionary<br />measure during concomitant therapy.</p><p><strong>Methotrexate</strong>: Diclofenac can inhibit the tubular renal clearance of methotrexate<br />hereby increasing methotrexate levels. Caution is recommended when NSAIDs,<br />including diclofenac, are administered less than 24 hours before treatment with<br />methotrexate, since blood concentrations of methotrexate may rise and the toxicity of<br />this substance be increase. Cases of serious toxicity have been reported when<br />methotrexate and NSAIDs including diclofenac are given within 24 hours of each<br />other. This interaction is mediated through accumulation of methotrexate resulting<br />from impairment of renal excretion in the presence of the NSAID.</p><p><strong>Ciclosporin</strong>: Diclofenac, like other NSAIDs, may increase the nephrotoxicity of<br />ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at<br />doses lower than those that would be used in patients not receiving ciclosporin.</p><p><strong>Tacrolimus</strong>: Possible increased risk of nephrotoxicity when NSAIDs are given with<br />tacrolimus. This might be mediated through renal antiprostagladin effects of both<br />NSAID and calcineurin inhibitor.</p><p><strong>Quinolone antibacterials:</strong> Convulsions may occur due to an interaction between<br />quinolones and NSAIDs. This may occur in patients with or without a previous<br />history of epilepsy or convulsions. Therefore, caution should be exercised when<br />considering the use of a quinolone in patients who are already receiving an NSAID.</p><p><strong>Phenytoin</strong>: When using phenytoin concomitantly with diclofenac, monitoring of<br />phenytoin plasma concentrations is recommended due to an expected increase in<br />exposure to phenytoin.</p><p><strong>Colestipol and cholestyramine: </strong>These agents can induce a delay or decrease in<br />absorption of diclofenac. Therefore, it is recommended to administer diclofenac at<br />least one hour before or 4 to 6 hours after administration of<br />colestipol/cholestyramine.</p><p><strong>Cardiac glycosides</strong>: Concomitant use of cardiac glycosides and NSAIDs in patients<br />may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><strong>Mifepristone</strong>: NSAIDs should not be used for 8-12 days after mifepristone<br />administration as NSAIDs can reduce the effect of mifepristone.</p><p><strong>Potent CYP2C9 inhibitors: </strong>Caution is recommended when co-prescribing<br />diclofenac with potent CYP2C9 inhibitors (such as sulfinpyrazone and voriconazole),<br />which could result in a significant increase in peak plasma concentrations and<br />exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong><br />Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the<br />embryo/fetal development. Data from epidemiological studies suggest an increased<br />risk of miscarriage and or cardiac malformation and gastroschisis after use of a<br />prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for<br />cardiovascular malformation was increased from less than 1% up to approximately<br />1.5%.<br />The risk in believed to increase with dose and duration of therapy. In animals,<br />administration of a prostaglandin synthesis inhibitor has shown to result in increased<br />pre-and post-implantation loss and embryo-foetal lethality.<br />In addition, increased incidences of various malformations, including cardiovascular,<br />have been reported in animals given a prostaglandin synthesis inhibitor during<br />organogenetic period. If Rofenac is used by a woman attempting to conceive, or<br />during the 1st trimester of pregnancy, the dose should be kept as low and duration of<br />treatment as short as possible.<br />During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may<br />expose the fetus to:<br />- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and<br />pulmonary hypertension)<br />- renal dysfunction, which may progress to renal failure with oligo-hydroamniosis<br />The mother and the neonate, at the end of the pregnancy, to:<br />- possible prolongation of bleeding time, an anti-aggregating effect which may occur<br />even at very low doses<br />- inhibition of uterine contractions resulting in delayed or prolonged labour<br />Consequently, Rofenac is contraindicated during the third trimester of pregnancy.<br />With reference to experience from treatment with NSAIDs with systemic uptake, the<br />following is recommended:<br />Consequently, Rofenac is contraindicated during the third trimester of pregnancy (see<br />section 4.3)</p><p><strong>Lactation</strong><br />Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore<br />Diclofenac should not be administered during breast feeding in order to avoid<br />undesirable effects in the infant.</p><p><strong>Female fertility</strong><br />As with other NSAIDs, the use of diclofenac may impair female fertility and is not<br />recommended in women attempting to conceive. In women who may have difficulties<br />conceiving or who are undergoing investigation of infertility, withdrawal of<br />diclofenac should be considered. See also section 4.4 Special warnings and<br />precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, vertigo, somnolence, central<br />nervous system disturbances, drowsiness or fatigue while taking NSAIDs should<br />refrain from driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common (&ge; 1/100, &lt;1/10); uncommon ( &ge;1/1,000, &lt;1/100); rare (&ge; 1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be estimated from available data.</p><p>The following undesirable effects include those reported with other short-term or long-term use.</p><p><strong>Table 1</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2"><p dir="LTR"><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p></td><td><p dir="LTR">Thrombocytopenia, leucopoenia, anemia (including hemolytic and aplastic anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Immune system disorders</strong></p></td></tr><tr><td><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td><p dir="LTR">Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p><p dir="LTR">Angioneurotic edema (including face edema).</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Psychiatric disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p></td><td><p dir="LTR">Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Nervous system disorders</strong></p></td></tr><tr><td><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">Very rare</p><p dir="LTR">Unknown</p></td><td><p dir="LTR">Headache, dizziness.</p><p dir="LTR">Somnolence, tiredness.</p><p dir="LTR">Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p><p dir="LTR">Confusion, hallucinations, disturbances of sensation, malaise.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Eye disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p><p dir="LTR">Unknown</p></td><td><p dir="LTR">Visual disturbance, vision blurred, diplopia.</p><p dir="LTR">Optic neuritis.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td><p dir="LTR">Common</p><p dir="LTR">Very rare</p></td><td><p dir="LTR">Vertigo.</p><p dir="LTR">Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Cardiac disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p></td><td><p dir="LTR">Palpitations, chest pain, cardiac failure, myocardial infarction.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Vascular disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p></td><td><p dir="LTR">Hypertension, hypotension, vasculitis.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td><p dir="LTR">Asthma (including dyspnoea).</p><p dir="LTR">Pneumonitis.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR"><br /><br /><br /><br /><br />Very rare</p></td><td><p dir="LTR">Nausea, vomiting, diarrhea, dyspepsia, abdominal pain, flatulence, anorexia.</p><p dir="LTR">Gastritis, gastrointestinal hemorrhage, haematemesis, diarrhea hemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly).</p><p dir="LTR">Colitis (including hemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td><p dir="LTR">Transaminases increased.</p><p dir="LTR">Hepatitis, jaundice, liver disorder.</p><p dir="LTR">Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td><p dir="LTR">Common</p><p dir="LTR">Rare</p><p dir="LTR">Very rare</p></td><td><p dir="LTR">Rash.</p><p dir="LTR">Urticaria.</p><p dir="LTR">Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Renal and urinary disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p></td><td><p dir="LTR">Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td><p dir="LTR">Rare</p></td><td><p dir="LTR">Edema</p></td></tr><tr><td colspan="2"><p dir="LTR"><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td><p dir="LTR">Very rare</p></td><td><p dir="LTR">Impotence.</p></td></tr></tbody></table><p>Clinical trial and epidemiological data suggest that use of diclofenac, particularly at high doses (150mg daily) and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4 Special warnings and special precautions for use)<em>. </em></p><p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common ( &ge;1/100, &lt;1/10); uncommon ( &ge;1/1,000, &lt;1/100); rare (&ge; 1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be estimated from available data.</p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><strong>Very rare<br />(&lt;1/10,000)</strong></td><td><strong>Rare<br />( &ge;1/10,000,<br />&lt;1/1,000)</strong></td><td><strong>Uncommon<br />( &ge;1/1,000,<br />&lt;1/100)</strong></td><td><strong>Common<br />(&ge; 1/100,<br />&lt;1/10)</strong></td><td><strong>Organ system</strong></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td><p>Eye pain,&nbsp;lacrimation&nbsp;disorder</p></td><td>Conjunctivitis</td><td><strong>Eye Disorders</strong></td></tr><tr><td>Gastrointestinal<br />hemorrhage</td><td>&nbsp;</td><td>Abdominal<br />pain, diarrhea,<br />nausea</td><td>&nbsp;</td><td><strong>Gastrointestinal<br />Disorders</strong></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>Application site<br />reactions<br />(including<br />inflammation,<br />irritation, pain<br />and tingling or<br />blistering at the<br />treatment site)</td><td><strong>General<br />Disorders and<br />Administration<br />Site Conditions</strong></td></tr><tr><td>Topical<br />application of<br />large amounts<br />may result in<br />systemic effects<br />including all<br />types of<br />hypersensitivity<br />(including<br />urticaria,<br />angioneurotic&nbsp;oedema)</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td><strong>Immune System<br />Disorders</strong></td></tr><tr><td>Rash pustular</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td><strong>Infections and<br />Infestations</strong></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>Hyperesthesia, Nervous System<br />hypertonia,<br />localised<br />paraesthesia</td><td><strong>Nervous System</strong></td></tr><tr><td>Renal failure</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td><strong>Renal and<br />Urinary System<br />Disorders</strong></td></tr><tr><td>Asthma</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td><strong>Respiratory,<br />Thoracic and<br />Mediastinal<br />Disorders</strong></td></tr><tr><td>Photosensitivity<br />reaction</td><td>Dermatitis<br />bullous</td><td>Alopecia, face<br />oedema,<br />maculopapular<br />rash,<br />seborrhoea</td><td>Dermatitis<br />(including<br />contact<br />dermatitis),<br />eczema, dry<br />skin, erythema,<br />edema,<br />pruritus, rash,<br />scaly rash, skin<br />hypertrophy,<br />skin ulcer,<br />vesiculobullous<br />rash</td><td><strong>Skin and<br />Subcutaneous<br />Tissue<br />Disorders</strong></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>Hemorrhage</td><td>&nbsp;</td><td><strong>Vascular<br />Disorders</strong></td></tr></tbody></table><p>&nbsp;</p><p>Temporary hair discoloration at the application site has been reported. This is usually<br />reversed on stopping treatment.</p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><p><strong>To report any side effect(s):</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p>&nbsp;The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p>&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong><br />There is no typical clinical picture resulting from diclofenac over dosage. Over<br />dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain,<br />gastrointestinal bleeding, diarrhea, dizziness, disorientation, excitation, coma,<br />drowsiness, tinnitus, fainting or convulsions. In the case of significant poisoning<br />acute renal failure and liver damage are possible.<br />&nbsp;</p><p><strong>Therapeutic measures</strong><br />Patients should be treated symptomatically as required. Within one hour of ingestion<br />of a potentially toxic amount, activated charcoal should be considered. Alternatively,<br />in adults gastric lavage should be considered within one hour of ingestion of<br />potentially toxic amounts. Frequent or prolonged convulsions should be treated with<br />intravenous diazepam. Other measures may be indicated by the patients clinical<br />condition.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group</strong><br />Nonsteroidal anti-inflammatory drugs (NSAIDs).</p><p><strong>Mechanism of action</strong><br />Rofenac is a nonsteroidal agent with marked analgesic/anti- inflammatory properties.<br />It is an inhibitor of prostaglandin synthetase, (cyclo-oxygenase).<br />Diclofenac sodium in vitro does not suppress proteoglycan biosynthesis in cartilage at<br />concentrations equivalent to the concentrations reached in human beings.<br /><u>12.5mg/25mg Suppositories only</u><br />There is a limited clinical trial experience of the use of diclofenac in JRA/JIA paediatric<br />patients. In a randomised, double-blind, 2-week, parallel group study in children aged 3-<br />15 years with JRA/JIA, the efficacy and safety of daily 2-3 mg/kg BW diclofenac was<br />compared with acetylsalicylic acid (ASS, 50-100 mg/kg BW/d) and placebo &ndash; 15 patients<br />in each group. In the global evaluation, 11 of 15 diclofenac patients, 6 of 12 aspirin and 4<br />of 15 placebo patients showed improvement with the difference being statistically<br />significant (p &lt;0.05). The number of tender joints decreased with diclofenac and ASS but<br />increased with placebo. In a second randomised, double-blind, 6 week, parallel group<br />study in children aged 4-15 years with JRA/JIA, the efficacy of diclofenac (daily dose 2-<br />3 mg/kg BW, n=22) was comparable with that of indomethacin (daily dose 2-3 mg/kg<br />BW, (n=23).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is limited kinetic data from 6 children aged 6-16 years with juvenile chronic<br />arthritis who received a once daily dose of diclofenac for 2 weeks. When corrected<br />for a body weight of 75kg, kinetic parameters were similar to those in adults. (12.5mg<br />and 25mg suppositories only)</p><p><em>Absorption</em><br />Absorption is rapid; although the rate of absorption is slower than from enteric-coated<br />tablets administered orally. After the administration of 50mg suppositories, peak<br />plasma concentrations are attained on average within 1 hour, but maximum<br />concentrations per dose unit are about two thirds of those reached after administration<br />of enteric-coated tablets (1.95 &plusmn; 0.8&mu;g/ml (1.9&mu;g/ml &equiv; 5.9&mu;mol/l)).</p><p><em>Bioavailability</em><br />As with oral preparations the AUC is approximately a half of the value obtained from<br />a parenteral dose.<br />Pharmacokinetic behaviour does not change on repeated administration.<br />Accumulation does not occur, provided the recommended dosage intervals are<br />observed.<br />The plasma concentrations attained in children given equivalent doses (mg/kg, b.w.)<br />are similar to those obtained in adults. (12.5mg and 25mg suppositories only)</p><p><em>Distribution</em><br />The active substance is 99.7% protein bound, mainly to albumin (99.4%).<br />Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-<br />4 hours after the peak plasma values have been attained. The apparent half-life for<br />elimination from the synovial fluid is 3-6 hours. Two hours after reaching the peak<br />plasma values, concentrations of the active substance are already higher in the<br />synovial fluid than they are in the plasma and remain higher for up to 12 hours.<br />Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one<br />nursing mother. The estimated amount ingested by an infant consuming breast milk is<br />equivalent to a 0.03 mg/kg/day dose (see section 4.6 Pregnancy and lactation).<br />&nbsp;</p><p><em>Metabolism</em><br />Biotransformation of diclofenac takes place partly by glucuronidation of the intact<br />molecule, but mainly by single and multiple hydroxylation and methoxylation,<br />resulting in several phenolic metabolites , most of which are converted to glucuronide<br />conjugates. Two phenolic metabolites are biologically active, but to a much lesser<br />extent than diclofenac.</p><p><em>Elimination</em><br />The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 mL/min (mean value<br />&plusmn; SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites,<br />including the two active ones, also have short plasma half-lives of 1-3 hours.<br />About 60% of the administered dose is excreted in the urine in the form of the<br />glucuronide conjugate of the intact molecule and as metabolites, most of which are<br />also converted to glucuronide conjugates. Less than 1% is excreted as unchanged<br />substance. The rest of the dose is eliminated as metabolites through the bile in the<br />faeces.</p><p><em>Characteristics in patients</em><br />No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or<br />excretion have been observed, other than the finding that in five elderly patients, a 15<br />minute iv infusion resulted in 50% higher plasma concentrations than expected with<br />young healthy subjects.<br />Patients with renal impairment: In patients suffering from renal impairment, no<br />accumulation of the unchanged active substance can be inferred from the single-dose<br />kinetics when applying the usual dosage schedule. At a creatinine clearance of less<br />than 10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites<br />are about 4 times higher than in normal subjects. However, the metabolites are<br />ultimately cleared through the bile.</p><p><em>Patients with hepatic disease:</em> In patients with chronic hepatitis or nondecompensated<br />cirrhosis, the kinetics and metabolism of diclofenac are the same as in<br />patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For Rofenac suppository:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:398px"><tbody><tr><td style="vertical-align:top"><p><strong>Excipients</strong></p></td></tr><tr><td style="vertical-align:top"><p>Witepsol H-15</p></td></tr><tr><td style="vertical-align:top"><p>Witepsol w-35</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rofenac suppositories:<br />10/pack (12.5mg and 25mg)<br />5/pack (100mg)<br />White Opaque Thermoformed PVC</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No Special Disposal</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>